Atlas Trials

Songling Xuemaikang Capsules for Cerebral Small Vessel Disease

Clinical trial NCT07271732 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07271732
Sponsor
Dongzhimen Hospital, Beijing
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HypertensionCerebral Small Vessel Diseases
Start date
2025-12-10
Primary completion
2026-12-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.